Important notice regarding Rhopressa

Posted in Latest News on February 12, 2019.

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa.



More Latest News

The MQA FY 23-24 Annual Report and Long-Range Plan is Here!
November 1, 2024

Check out the report on the MQA Reports and Publications page to see how MQA is advancing its mission to make Florida the healthiest state in the nation. Continue reading →


Hurricane Milton Early Prescription Refills Permitted Under State of Emergency
October 16, 2024

On October 5, 2024, Governor Ron DeSantis declared a state of emergency to prepare for Hurricane Milton. Continue reading →